Salm Partners, LLC, Recalls Johnsonville Polish Kielbasa Turkey Sausage Products

Due to Possible Foreign Matter Contamination

Translate to Spanish or other 102 languages!

Salm Partners, LLC, a Denmark, Wis., establishment, is recalling approximately 35,430 pounds of Johnsonville turkey kielbasa sausage that may be contaminated with foreign materials, specifically pieces of rubber, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) announced. Image for illustration purposes
Salm Partners, LLC, a Denmark, Wis., establishment, is recalling approximately 35,430 pounds of Johnsonville turkey kielbasa sausage that may be contaminated with foreign materials, specifically pieces of rubber, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced. Image for illustration purposes
- Advertisement -

USDA Food Safety and Inspection Services

WASHINGTON, DC- Salm Partners, LLC, a Denmark, Wis., establishment, is recalling approximately 35,430 pounds of Johnsonville turkey kielbasa sausage that may be contaminated with foreign materials, specifically pieces of rubber, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced.

The turkey kielbasa sausages were produced between Oct. 30-31, 2023. The following products are subject to recall [view labels]:

- Advertisement -
  • 12-oz. vacuum-packed packages containing a single piece of “Johnsonville POLISH KIELBASA TURKEY” sausage and best by dates “05/17/24” and “05/18/24” printed on the side of the packaging.

The products subject to recall bear establishment number “P-32009” printed on the side of the packaging. These items were shipped to retail locations nationwide.

The problem was discovered after the firm received complaints from consumers reporting they found pieces of rubber in the ready-to-eat turkey kielbasa products.

There have been no confirmed reports of adverse reactions or injury due to consumption of these products. Anyone concerned about an injury should contact a healthcare provider.

FSIS is concerned that some product may be in consumers’ refrigerators. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.

- Advertisement -

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify theircustomers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution list(s) will be posted on the FSIS website at www.fsis.usda.gov/recalls.

Consumers and members of the media with questions about the recall can contact Stephanie Schafer, Director of Global Corporate Communications for Johnsonville, at 888-556-2728 or sschafer@johnsonville.com.

Consumers with food safety questions can call the toll-free USDA Meat and Poultry Hotline at 888-MPHotline (888-674-6854) or send a question via email to MPHotline@usda.gov. For consumers that need to report a problem with a meat, poultry, or egg product, the online Electronic Consumer Complaint Monitoring System can be accessed 24 hours a day at https://foodcomplaint.fsis.usda.gov/eCCF/.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Effective Ways to Fight Back Against Mosquitoes

As the temperatures continue to climb this summer, you’re sure to see more pesky mosquitoes buzzing around.So, what can you do to help keep them away?

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -